68Ga-DOTA.SA.FAPI as a Potential, Noninvasive Diagnostic Probe for Recurrent and Metastatic Adrenocortical Carcinoma: A Head-to-Head Comparison With 18F-FDG : Clinical Nuclear Medicine

Secondary Logo

Journal Logo

Interesting Images

68Ga-DOTA.SA.FAPI as a Potential, Noninvasive Diagnostic Probe for Recurrent and Metastatic Adrenocortical Carcinoma

A Head-to-Head Comparison With 18F-FDG

Chopra, Sejal MSc∗; Walia, Rama MD†; Mathur, Yamini MD, DNB∗; Roesch, Frank PhD‡; Moon, Euy Sung PhD‡; Rana, Nivedita PhD∗; Pandey, Somit MSc∗; Chatterji, Debajyoti DM§; Kumar, Rajender MD∗; Singh, Harmandeep MD∗; Mittal, Bhagwant Rai MD, DNB∗; Shukla, Jaya PhD∗

Author Information
Clinical Nuclear Medicine 48(4):p e173-e175, April 2023. | DOI: 10.1097/RLU.0000000000004563

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid